✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Samrat Pharmachem Ltd.

SAMRATPH

Market Cap
₹106 Cr.
P/E
11.86

Samrat Pharmachem Ltd.

  • Samrat Pharmachem
  • Source Natural Foods
  • Parnax Lab
FAQs on Samrat Pharmachem Ltd. Shareprice

Samrat Pharmachem has given better returns compared to its competitors.
Samrat Pharmachem has grown at ~36.75% over the last 5yrs while peers have grown at a median rate of 12.0%

Samrat Pharmachem is not expensive.
Latest PE of Samrat Pharmachem is 11.86, while 3 year average PE is 17.47.
Also latest EV/EBITDA of Samrat Pharmachem is 9.44 while 3yr average is 25.35.

View FAQ's On Business
Growth Table
  • Samrat Pharmachem Ltd.
  • Source Natural Foods
  • Parnax Lab
Balance Sheet
  • Samrat Pharmachem Ltd.
  • Source Natural Foods
  • Parnax Lab
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Samrat Pharmachem Ltd.
  • Source Natural Foods
  • Parnax Lab
Cash Flow
  • Samrat Pharmachem Ltd.
  • Source Natural Foods
  • Parnax Lab
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Samrat Pharmachem Ltd.
  • Source Natural Foods
  • Parnax Lab
Quarterly Results
  • Samrat Pharmachem Ltd.
  • Source Natural Foods
  • Parnax Lab
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Samrat Pharmachem Ltd. Financials

Balance sheet of Samrat Pharmachem is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Samrat Pharmachem is increasing.
Latest net debt of Samrat Pharmachem is ₹2.25 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹10.95 Crs.

The profit is oscillating.
The profit of Samrat Pharmachem is ₹8.91 Crs for TTM, ₹2.16 Crs for Mar 2024 and ₹16.63 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Samrat Pharmachem latest dividend payout ratio is 14.29% and 3yr average dividend payout ratio is 5.98%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech